Le Lézard
Classified in: Health
Subjects: CCA, PET

Heska Third Quarter 2021 Financial Results and Earnings Call Scheduled for November 4, 2021


LOVELAND, Colo., Oct. 12, 2021 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company"), a leading provider of advanced veterinary diagnostic and specialty products, will report its third quarter 2021 financial performance in a press release before the market opens on Thursday, November 4, 2021. The Company will also host an earnings call at 9 a.m. MT / 11 a.m. ET to discuss the results.

To access the conference call:
    From within the United States, please dial 1-888-394-8218
    From outside of the United States, please dial 1-323-701-0225
    Reference Conference ID: 2365183

The earnings call will be webcast live from the Company's investor relations website at Heska Third Quarter 2021 Earnings Call Webcast.

A telephonic replay will be available at 2 p.m. ET on November 4 through 11:59 p.m. ET on November 18, 2021 and the webcast will be archived on the Company's website for 90 days.

To access the replay:
    From within the United States, please dial 1-844-512-2921
    From outside the United States, please dial 1-412-317-6671
    Reference Replay Pin Number: 2365183

About Heska
Heska Corporation (NASDAQ: HSKA) manufactures, develops and sells advanced veterinary diagnostic and specialty healthcare products through its two business segments: North America and International. Both segments include Point of Care Lab testing instruments and consumables, digital imaging products, software and services, data services, allergy testing and immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. The North America segment also includes private label vaccine and pharmaceutical production under third-party agreements and channels, primarily for herd animal health. For more information, please visit www.heska.com.

Heska Corporation (PRNewsfoto/Heska Corporation)

 

SOURCE Heska Corporation


These press releases may also interest you

19 avr 2024
Remedium Healthcare Products is proud to announce the launch of NuVeria Labs' revolutionary Sacral Silicone Dressing, now available for purchase on Amazon, bringing advanced wound care solutions directly to consumers' doorsteps. Designed to address...

19 avr 2024
Getting specialty medications into...

19 avr 2024
Arthrex, a global leader in minimally invasive surgical technology, has once again taken home prestigious medals for product innovation at the 37th annual Edison Awards. "This product, along with our other innovations,...

19 avr 2024
Aligned with the trend of immersive water therapy in 2024, Baros Maldives' Serenity Spa stands out as an oasis of indulgent spa and beauty rituals, boasting a 50-year legacy of luxury. Nestled within a tranquil sanctuary amidst the lush Maldivian...

19 avr 2024
Oragenics, Inc. , a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated April...

19 avr 2024
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...



News published on and distributed by: